These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1787880)

  • 1. Effects of benzodiazepine receptor antagonist, flumazenil, on antinociceptive and behavioural responses to the elevated plus-maze in mice.
    Lee C; Rodgers RJ
    Neuropharmacology; 1991 Dec; 30(12A):1263-7. PubMed ID: 1787880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience.
    Rodgers RJ; Lee C; Shepherd JK
    Psychopharmacology (Berl); 1992; 106(1):102-10. PubMed ID: 1738787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus maze.
    Rex A; Marsden CA; Fink H
    Psychopharmacology (Berl); 1993; 110(4):490-6. PubMed ID: 7532862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance.
    Dalvi A; Rodgers RJ
    Pharmacol Biochem Behav; 1999 Apr; 62(4):727-34. PubMed ID: 10208379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
    Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations.
    Lee C; Rodgers RJ
    Psychopharmacology (Berl); 1990; 102(4):507-13. PubMed ID: 1965750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of flumazenil, Ro 15-4513 and beta-CCM on the behaviour of control and stressed mice in the plus-maze test.
    Pokk P; Zharkovsky A
    J Physiol Pharmacol; 1997 Jun; 48(2):253-61. PubMed ID: 9223029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
    Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
    Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepine/GABA(A) receptors are involved in magnesium-induced anxiolytic-like behavior in mice.
    Poleszak E
    Pharmacol Rep; 2008; 60(4):483-9. PubMed ID: 18799816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test.
    Barbalho CA; Nunes-de-Souza RL; Canto-de-Souza A
    Brain Res; 2009 Apr; 1267():65-76. PubMed ID: 19268657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiogenic effects of the intraamygdala injection of flumazenil, a benzodiazepine receptor antagonist.
    Da Cunha C; Wolfman C; Levi de Stein M; Ruschel AC; Izquierdo I; Medina JH
    Funct Neurol; 1992; 7(5):401-5. PubMed ID: 1338052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.
    Chopin P; Briley M
    Psychopharmacology (Berl); 1993; 110(4):409-14. PubMed ID: 7870910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of drugs acting at GABA-benzodiazepine-barbiturate receptor complex on the behaviour of sleep-deprived mice.
    Pokk P; Zharkovsky A
    Pharmacol Toxicol; 1995 Jan; 76(1):23-8. PubMed ID: 7753752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety-like behavior in elevated plus-maze tests in repeatedly cold-stressed mice.
    Hata T; Nishikawa H; Itoh E; Funakami Y
    Jpn J Pharmacol; 2001 Feb; 85(2):189-96. PubMed ID: 11286402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.
    Schmidt-Mutter C; Pain L; Sandner G; Gobaille S; Maitre M
    Eur J Pharmacol; 1998 Jan; 342(1):21-7. PubMed ID: 9544788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor.
    Baldwin HA; File SE
    Brain Res Bull; 1988 May; 20(5):603-6. PubMed ID: 2838131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of buspirone on antinociceptive and behaviourial responses to the elevated plus-maze in mice.
    Lee C; Rodgers RJ
    Behav Pharmacol; 1991 Dec; 2(6):491-496. PubMed ID: 11224091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam.
    Nunes-de-Souza RL; Canto-de-Souza A; da-Costa M; Fornari RV; Graeff FG; Pelá IR
    Psychopharmacology (Berl); 2000 Jun; 150(3):300-10. PubMed ID: 10923758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LY 171555-induced hyperdefensiveness in the mouse does not implicate benzodiazepine receptors.
    Belzung C; Cabib S; Fabiani L; Tolentino P; Puglisi-Allegra S
    Psychopharmacology (Berl); 1991; 103(4):449-54. PubMed ID: 1676525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.